Chung Jane
Insider CIK 1872398 · VIRX Director · STRO President and COO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2026-03-04 | 2026-03-06 | 788 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2026-03-04 | 2026-03-06 | 788 | — | $0 | 21,567 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2026-03-04 | 2026-03-06 | 282 | $21.31 | $6.0K | 21,285 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2026-03-02 | 2026-03-03 | 175,000 | — | $0 | 175,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2026-03-02 | 2026-03-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2026-03-02 | 2026-03-03 | 7,750 | — | $0 | 23,250 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2026-03-02 | 2026-03-03 | 7,750 | — | $0 | 23,558 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2026-03-02 | 2026-03-03 | 2,779 | $20.55 | $57.1K | 20,779 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2026-03-01 | 2026-03-03 | 2,500 | — | $0 | 5,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2026-03-01 | 2026-03-03 | 688 | — | $0 | 688 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2026-03-01 | 2026-03-03 | 688 | — | $0 | 14,579 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2026-03-01 | 2026-03-03 | 2,500 | — | $0 | 17,079 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2026-03-01 | 2026-03-03 | 1,271 | $20.47 | $26.0K | 15,808 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2025-12-12 | 2025-12-16 | 2,500 | — | $0 | 5,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2025-12-12 | 2025-12-16 | 2,500 | — | $0 | 14,785 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2025-12-12 | 2025-12-16 | 894 | $8.02 | $7.2K | 13,891 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | P Buy | 2025-10-15 | 2025-10-16 | 12,500 | $0.80 | $10.0K | 122,850 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2025-08-09 | 2025-08-26 | 18,750 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2025-08-09 | 2025-08-26 | 6,708 | $0.80 | $5.4K | 110,350 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2025-08-09 | 2025-08-26 | 18,750 | — | $0 | 117,058 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2025-04-04 | 2025-04-08 | 310,000 | — | $0 | 310,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2025-04-04 | 2025-04-08 | 620,000 | — | $0 | 620,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2025-03-04 | 2025-03-06 | 7,875 | — | $0 | 7,875 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2025-03-04 | 2025-03-06 | 2,334 | $1.42 | $3.3K | 98,308 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2025-03-04 | 2025-03-06 | 7,875 | — | $0 | 100,642 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2025-03-01 | 2025-03-04 | 25,000 | — | $0 | 75,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2025-03-01 | 2025-03-04 | 6,875 | — | $0 | 13,750 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2025-03-01 | 2025-03-04 | 25,000 | — | $0 | 102,217 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2025-03-01 | 2025-03-04 | 6,875 | — | $0 | 77,217 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2025-03-01 | 2025-03-04 | 9,450 | $1.59 | $15.0K | 92,767 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2024-12-01 | 2024-12-03 | 25,000 | — | $0 | 75,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2024-12-01 | 2024-12-03 | 25,000 | — | $0 | 79,262 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2024-12-01 | 2024-12-03 | 8,920 | $2.69 | $24.0K | 70,342 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2024-08-09 | 2024-08-13 | 18,750 | — | $0 | 18,750 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2024-08-09 | 2024-08-13 | 18,750 | — | $0 | 60,951 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2024-08-09 | 2024-08-13 | 6,689 | $3.12 | $20.9K | 54,262 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2024-03-05 | 2024-03-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2024-03-05 | 2024-03-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2024-03-04 | 2024-03-06 | 7,875 | — | $0 | 15,750 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2024-03-04 | 2024-03-06 | 2,209 | $4.79 | $10.6K | 42,201 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2024-03-04 | 2024-03-06 | 7,875 | — | $0 | 44,410 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2024-03-01 | 2024-03-05 | 6,875 | — | $0 | 20,625 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2024-03-01 | 2024-03-05 | 2,038 | $4.95 | $10.1K | 36,535 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2024-03-01 | 2024-03-05 | 6,875 | — | $0 | 38,573 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2023-12-01 | 2023-12-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2023-12-01 | 2023-12-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2023-08-09 | 2023-08-11 | 18,750 | — | $0 | 37,500 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2023-08-09 | 2023-08-11 | 6,483 | $4.22 | $27.4K | 31,698 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2023-08-09 | 2023-08-11 | 18,750 | — | $0 | 38,181 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2023-06-08 | 2023-06-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2023-03-03 | 2023-03-07 | 27,500 | — | $0 | 27,500 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2023-03-03 | 2023-03-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2023-03-03 | 2023-03-07 | 7,875 | — | $0 | 23,625 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2023-03-03 | 2023-03-07 | 3,211 | $5.79 | $18.6K | 19,431 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2023-03-03 | 2023-03-07 | 7,875 | — | $0 | 22,642 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2022-08-10 | 2022-08-11 | 80,000 | — | $0 | 80,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise deriv | 2022-08-09 | 2022-08-10 | 18,750 | — | $0 | 56,250 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | M Exercise | 2022-08-09 | 2022-08-10 | 18,750 | — | $0 | 21,250 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | F Tax w/h | 2022-08-09 | 2022-08-10 | 6,483 | $6.60 | $42.8K | 14,767 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2022-03-04 | 2022-03-07 | 42,000 | — | $0 | 42,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2022-03-04 | 2022-03-07 | 31,500 | — | $0 | 31,500 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2021-08-09 | 2021-08-11 | 75,000 | — | $0 | 75,000 | SEC↗ |
| STRO SUTRO BIOPHARMA, INC. | A Award deriv | 2021-08-09 | 2021-08-11 | 160,000 | — | $0 | 160,000 | SEC↗ |